Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17051-17100 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05490771
Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)
PHASE2
Active, not recruiting
35 participants
Started: Jun 20, 2018 · Completed: Dec 31, 2025
6 conditions
1 sponsor
1 location
NCT03449381
This Study Aims to Find the Best Dose of BI 907828 (Brigimadlin) in Patients With Different Types of Advanced Cancer (Solid Tumors)
PHASE1
Active, not recruiting
266 participants
Started: Jun 20, 2018 · Completed: Oct 20, 2025
1 condition
1 sponsor
27 locations
NCT03475212
Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation
PHASE1/PHASE2
Active, not recruiting
52 participants
Started: Jun 20, 2018 · Completed: Jun 30, 2025
3 conditions
1 sponsor
30 locations
NCT03626038
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
NA
Active, not recruiting
135 participants
Started: Jun 19, 2018 · Completed: Dec 31, 2025
5 conditions
1 sponsor
7 locations
NCT03506451
PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study
NA
Active, not recruiting
60 participants
Started: Jun 19, 2018 · Completed: Nov 29, 2025
1 condition
1 sponsor
1 location
NCT03399851
Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO)
NA
Active, not recruiting
200 participants
Started: Jun 19, 2018 · Completed: May 31, 2026
1 condition
1 sponsor
8 locations
NCT04208685
Evaluating Cognitive Outcomes in Down Syndrome
N/A
Active, not recruiting
202 participants
Started: Jun 18, 2018 · Completed: Jun 30, 2026
1 condition
2 sponsors
2 locations
NCT04427579
Anxiety and Depression in COPD; Prevalence, Detection and Prognosis
N/A
Active, not recruiting
200 participants
Started: Jun 15, 2018 · Completed: Dec 31, 2025
3 conditions
4 sponsors
1 location
NCT03484130
Prospective Phenotyping of Autonomous Aldosterone Secretion
N/A
Active, not recruiting
100 participants
Started: Jun 15, 2018 · Completed: Jul 1, 2029
3 conditions
2 sponsors
1 location
NCT03543969
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma
EARLY_PHASE1
Active, not recruiting
14 participants
Started: Jun 14, 2018 · Completed: Dec 31, 2028
4 conditions
1 sponsor
1 location
NCT03637686
IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer
N/A
Active, not recruiting
3,182 participants
Started: Jun 14, 2018 · Completed: Jul 1, 2035
1 condition
2 sponsors
10 locations
NCT05975424
LTFU Study of Subjects With Cervical SCI Who Received AST-OPC1
N/A
Active, not recruiting
25 participants
Started: Jun 13, 2018 · Completed: Jan 14, 2033
1 condition
1 sponsor
6 locations
NCT06410677
Changhai Multimodal Esophageal Cancer Cohort
N/A
Active, not recruiting
110 participants
Started: Jun 13, 2018 · Completed: Oct 1, 2024
1 condition
1 sponsor
1 location
NCT04013152
Clinical Database of Colorectal Robotic Surgery
N/A
Active, not recruiting
1,800 participants
Started: Jun 13, 2018 · Completed: Jun 9, 2027
7 conditions
1 sponsor
4 locations
NCT03547947
Clinical and Radiological Outcomes of Medacta Shoulder System
N/A
Active, not recruiting
200 participants
Started: Jun 13, 2018 · Completed: Apr 30, 2031
7 conditions
1 sponsor
6 locations
NCT03565835
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
PHASE2
Active, not recruiting
32 participants
Started: Jun 13, 2018 · Completed: Jan 17, 2023
1 condition
1 sponsor
1 location
NCT03557359
Nivolumab for Recurrent or Progressive IDH Mutant Gliomas
PHASE2
Active, not recruiting
20 participants
Started: Jun 12, 2018 · Completed: Dec 31, 2026
1 condition
2 sponsors
4 locations
NCT03566667
Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease
PHASE4
Active, not recruiting
1,713 participants
Started: Jun 12, 2018 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT03567642
A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
PHASE1
Active, not recruiting
11 participants
Started: Jun 12, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
7 locations
NCT03626350
Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy
N/A
Active, not recruiting
250 participants
Started: Jun 12, 2018 · Completed: Jun 12, 2025
6 conditions
1 sponsor
1 location
NCT03304639
Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma
PHASE2
Active, not recruiting
9 participants
Started: Jun 12, 2018 · Completed: Sep 19, 2026
8 conditions
1 sponsor
255 locations
NCT06972693
NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma
PHASE4
Active, not recruiting
323 participants
Started: Jun 12, 2018 · Completed: Dec 30, 2025
3 conditions
1 sponsor
1 location
NCT03459456
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
N/A
Active, not recruiting
27 participants
Started: Jun 11, 2018 · Completed: Jul 31, 2026
2 conditions
3 sponsors
3 locations
NCT03516942
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
N/A
Active, not recruiting
565 participants
Started: Jun 11, 2018 · Completed: Sep 1, 2028
18 conditions
2 sponsors
716 locations
NCT03540745
Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders
NA
Active, not recruiting
14 participants
Started: Jun 11, 2018 · Completed: Nov 30, 2019
4 conditions
2 sponsors
1 location
NCT03632356
A Multi-Site RCT of a Stepped-Care Intervention for Emergency Department Patients With Panic Attacks and Panic Disorder
NA
Active, not recruiting
79 participants
Started: Jun 11, 2018 · Completed: Nov 30, 2024
1 condition
4 sponsors
1 location
NCT03308305
Cracking Coma: Towards EEG and MRI Based Precision Medicine After Cardiac Arrest
N/A
Active, not recruiting
100 participants
Started: Jun 11, 2018 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT03755791
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy
PHASE3
Active, not recruiting
837 participants
Started: Jun 10, 2018 · Completed: Dec 1, 2024
1 condition
1 sponsor
245 locations
NCT03392181
PET/MRI for the Staging of Newly Diagnosed Prostate Cancer
EARLY_PHASE1
Active, not recruiting
48 participants
Started: Jun 8, 2018 · Completed: Jun 1, 2026
1 condition
2 sponsors
1 location
NCT03507049
Sacroiliac Joint Fusion Versus Sham Operation for Treatment of Sacroiliac Joint Pain
NA
Active, not recruiting
63 participants
Started: Jun 8, 2018 · Completed: May 25, 2030
1 condition
2 sponsors
2 locations
NCT03441971
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
NA
Active, not recruiting
15 participants
Started: Jun 7, 2018 · Completed: Mar 31, 2030
4 conditions
1 sponsor
3 locations
NCT03562572
FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease
NA
Active, not recruiting
476 participants
Started: Jun 7, 2018 · Completed: Jul 31, 2027
5 conditions
9 sponsors
9 locations
NCT03294083
A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma
PHASE1/PHASE2
Active, not recruiting
89 participants
Started: Jun 7, 2018 · Completed: Nov 30, 2023
1 condition
2 sponsors
18 locations
NCT03377543
Sleep and Inflammatory Resolution Pathway
EARLY_PHASE1
Active, not recruiting
66 participants
Started: Jun 6, 2018 · Completed: Dec 30, 2025
4 conditions
1 sponsor
1 location
NCT03448042
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
PHASE1
Active, not recruiting
123 participants
Started: Jun 6, 2018 · Completed: Dec 30, 2026
1 condition
1 sponsor
27 locations
NCT03498378
Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1
Active, not recruiting
24 participants
Started: Jun 6, 2018 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT03387553
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
EARLY_PHASE1
Active, not recruiting
31 participants
Started: Jun 6, 2018 · Completed: Aug 29, 2026
8 conditions
2 sponsors
1 location
NCT02965716
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
PHASE2
Active, not recruiting
43 participants
Started: Jun 5, 2018 · Completed: Nov 18, 2025
8 conditions
1 sponsor
20 locations
NCT03514069
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma
PHASE1
Active, not recruiting
60 participants
Started: Jun 5, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03210714
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
PHASE2
Active, not recruiting
20 participants
Started: Jun 5, 2018 · Completed: Dec 31, 2025
32 conditions
1 sponsor
116 locations
NCT03835663
The Bacterial Composition of the Stomach in Reflux Disease
N/A
Active, not recruiting
100 participants
Started: Jun 4, 2018 · Completed: Dec 31, 2024
8 conditions
1 sponsor
1 location
NCT03539614
Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests
PHASE3
Active, not recruiting
87 participants
Started: Jun 4, 2018 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT03600649
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
PHASE1
Active, not recruiting
50 participants
Started: Jun 4, 2018 · Completed: Dec 31, 2025
11 conditions
2 sponsors
16 locations
NCT03541083
Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.
PHASE2
Active, not recruiting
71 participants
Started: Jun 4, 2018 · Completed: Dec 15, 2026
1 condition
1 sponsor
18 locations
NCT03645824
Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF)
PHASE2
Active, not recruiting
61 participants
Started: Jun 4, 2018 · Completed: Feb 28, 2027
1 condition
3 sponsors
12 locations
NCT03363932
French Observatory of Congenital Ventricular Septal Defect With Pulmonary Overload
N/A
Active, not recruiting
218 participants
Started: Jun 1, 2018 · Completed: Jun 30, 2030
1 condition
1 sponsor
4 locations
NCT03323554
Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence
NA
Active, not recruiting
20 participants
Started: Jun 1, 2018 · Completed: Dec 1, 2026
1 condition
2 sponsors
1 location
NCT06268470
Antiplatelet Therapy in Chronic Urticaria
PHASE2
Active, not recruiting
12 participants
Started: Jun 1, 2018 · Completed: May 1, 2024
1 condition
1 sponsor
1 location
NCT03060434
Pentoxifylline and Lumbar Radiculopathy
PHASE4
Active, not recruiting
67 participants
Started: Jun 1, 2018 · Completed: Dec 1, 2026
3 conditions
1 sponsor
1 location
NCT04373993
Prehospital Minutes Count During a Stroke.
N/A
Active, not recruiting
1,100 participants
Started: Jun 1, 2018 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
339
340
341
342
343
344
345
More pages
431
Next